Skip to main content
JSW Dulux Limited logo

JSW Dulux Limited — Investor Relations & Filings

Ticker · JSWDULUX ISIN · INE133A01011 BSE.NS Manufacturing
Open in API
Filings indexed 2,253 across all filing types
Latest filing 2025-07-02 Regulatory Filings
Country IN India
Listing BSE.NS JSWDULUX

About JSW Dulux Limited

https://www.jswpaints.in/

JSW Dulux Limited specializes in the development, manufacture, and distribution of a comprehensive range of decorative and industrial coating solutions. The company’s portfolio includes interior and exterior emulsions, protective finishes, enamels, and specialized wood coatings designed for both residential and commercial applications. Utilizing advanced chemical formulations, the organization focuses on delivering high-performance products characterized by durability, color precision, and environmental sustainability. Key offerings feature low-VOC compositions, weather-resistant technologies, and anti-microbial properties. The company serves a broad market spectrum, providing technical coating systems for infrastructure projects alongside consumer-grade paints. Its operations emphasize innovation in surface protection and aesthetic enhancement through rigorous research and development.

Recent filings

Filing Released Lang Actions
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, disclosing litigation details related to a GST dispute. It is addressed to stock exchanges and includes a brief annexure describing the litigation, expected financial implications, and management's view. The document is short (3142 characters) and serves as a regulatory disclosure of pending litigation rather than a full legal proceedings report or financial report. It does not contain detailed financial statements or comprehensive legal analysis but is a formal announcement of litigation information as required by listing regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-07-02 English
Please find attached details of a show cause notice received from Maharashtra GST Department.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, disclosing litigation details related to a GST dispute. It is addressed to stock exchanges and provides information about pending litigation and its financial implications. The document is short (3142 characters) and serves as a regulatory disclosure rather than a full report or financial statement. It does not contain financial statements or detailed analysis but is a compliance announcement about litigation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-07-02 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited addressed to stock exchanges, providing an update on pending litigation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It references a previous disclosure and provides details of a litigation matter related to GST demand and amnesty order. The document is an update announcement about litigation status, not a full legal proceedings report or a detailed financial report. It is regulatory in nature, providing compliance information as required by SEBI regulations. The document length is 3873 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-28 English
Please find attached an update to our earlier disclosure made on 18th March 2025 regarding a demand from WB GST Dept.
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited addressed to stock exchanges, providing an update on pending litigation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It references a previous disclosure and provides details of a GST litigation matter, including an amnesty order received. The document is relatively short (3873 characters) and serves as an update or announcement rather than a full report. It does not contain comprehensive financial statements or detailed financial analysis. The content fits the description of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-06-28 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding a litigation matter under SEBI regulations. It discloses details about a pending litigation involving the company and the Haryana GST Department, including the financial implications and management's view on the outcome. The document is short (3134 characters) and serves as an intimation or disclosure under regulatory requirements, specifically under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It does not contain financial statements, audit opinions, or detailed financial results. It is not a full report but a regulatory announcement about litigation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-28 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It discloses information about pending litigation and its potential financial impact on the company. The document is short (3127 characters) and primarily serves as an intimation or announcement of litigation details rather than a full legal proceedings report or detailed financial report. It does not contain comprehensive financial statements or detailed management analysis but is a regulatory disclosure of litigation status. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.